MedPath

ORPHENADRINE CITRATE

Orphenadrine Citrate Extended-Release TabletsRx Only

Approved
Approval ID

7b76c8a7-dd0c-481c-8299-26dfd38ce066

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 10, 2025

Manufacturers
FDA

Lupin Pharmaceuticals, Inc.

DUNS: 089153071

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ORPHENADRINE CITRATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code43386-480
Application NumberANDA040284
Product Classification
M
Marketing Category
C73584
G
Generic Name
ORPHENADRINE CITRATE
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 10, 2025
FDA Product Classification

INGREDIENTS (4)

HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
ORPHENADRINE CITRATEActive
Quantity: 100 mg in 1 1
Code: X0A40N8I4S
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 9/10/2025

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Orphenadrine Citrate Extended-Release Tablets, 100 mg

Container Label

NDC 43386-480-24

100 ct

DESCRIPTION SECTION

LOINC: 34089-3Updated: 9/10/2025

DESCRIPTION

Orphenadrine citrate is the citrate salt of orphenadrine. It occurs as a white, crystalline powder having a bitter taste. It is practically odorless; sparingly soluble in water, slightly soluble in alcohol. The chemical name of orphenadrine citrate is (±)-N,N-Dimethyl-2-[(o-methyl-α- phenylbenzyl)oxy]ethylamine citrate (1:1) having molecular formula C18H23NO•C6H8O7 and molecular weight of 461.51. It has the following structural formula:

Image

Each tablet for oral administration contains 100 mg orphenadrine citrate. Each Orphenadrine citrate extended- release tablet contains the following inactive ingredients: hydroxypropyl methylcellulose, lactose monohydrate and magnesium stearate.

HOW SUPPLIED SECTION

LOINC: 34069-5Updated: 9/10/2025

HOW SUPPLIED

Orphenadrine citrate extended-release tablets 100 mg are round, white to off- white tablets, debossed NL4 on one side and plain on the other side and are supplied as:

NDC 43386-480-24 in bottles of 100 tablets

NDC 43386-480-26 in bottles of 500 tablets

NDC 43386-480-28 in bottles of 1000 tablets

Store at 20°-25°C (68°-77°F) [see USP Controlled Room Temperature].

Dispense in a tight, light-resistant container.

LUPIN and the lupin symbol are registered trademarks of Lupin Pharmaceuticals, Inc.

Manufactured by

Novel Laboratories, Inc.

Somerset, NJ 08873

Manufactured For

Lupin Pharmaceuticals, Inc.

Naples FL, 34108

SAP Code: 276510

Rev: 10/2024

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ORPHENADRINE CITRATE - FDA Drug Approval Details